Home › Essential Thrombocythemia › Alabama
Essential Thrombocythemia clinical trials in Alabama
3 studies for Essential Thrombocythemia are looking for participants at sites in Alabama.
Cities in Alabama
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
- University of Alabama At Birmingham, Birmingham
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT07441694A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
- University of Alabama At Birmingham Comprehensive Cancer Center, Birmingham
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT07623200A Study to Evaluate DMR-001 in Participants With CALR-mutant Myeloproliferative Neoplasms
- Site US07, Birmingham
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT07849231From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.